Pagaya Technologies: Another One-Buck SPAC Casualty (NASDAQ:PGY) – Seeking Alpha

Artificial Intelligence concept brain with CPU

MF3d

MF3d
On the throne of the world, any delusion can become fact.” ― Gore Vidal, Julian
Today, we are going to take our first look at a small cap company called Pagaya Technologies Ltd. (NASDAQ:PGY). As can be seen in the chart below, the shares have imploded in recent months. That said, revenue growth is impressive and the stock has a reasonable price to sales ratio. An analysis follows below.

Stock Chart

Seeking Alpha

Seeking Alpha

The engine behind the infrastructure

November Company Presentation

November Company Presentation
Pagaya Technologies Ltd. is located in Tel Aviv, Israel. The company develops and implements proprietary artificial intelligence technology and related software solutions to assist partners to originate loans and other asset. Its partners/clients include high-growth financial technology companies, incumbent financial institutions, auto finance providers, and brokers.

Partners join Pagaya's network because…

November Company Presentation

November Company Presentation
The company was founded in 2016 and went public through a SPAC called EJF Acquisition (EJFA) early this year. At the time, the entity had a pro forma implied enterprise value of $8.5 billion. The stock now sells for a buck a share and has an approximate market capitalization of just $700 million.

Our business model is a B2B2C platform

November Company Presentation

November Company Presentation
Management is focused on building the artificial intelligence infrastructure for the financial ecosystem. The company acts as the intermediary between its funding investors and its partners who receive loan applications from their clients such as auto dealerships, banks and other financial institutions.

Upfront funding

November Company Presentation

November Company Presentation
Pagaya believes its AI driven platform can reduce delinquency rates as well as reach more customers.
On November 4th, Pagaya posted third quarter numbers. The company had a non-GAAP loss of two cents a share. Adjusted EBITDA was a negative $5.2 million for the quarter. The adjusted net loss for the quarter was $14.4 million. Revenue rose just over 49% on a year-over-year basis to $204 million, which beat the consensus by over $25 million.

3Q financial highlights

November Company Presentation

November Company Presentation
Network volume was up 26% from the same period a year ago, to $1.9 billion. 41 million applications were evaluated in the first nine months of 2022, representing 120% growth compared to the same period last year.

3Q'22 financial highlights

November Company Presentation

November Company Presentation
Three weeks ago, both Wedbush and Moffett Nathanson reiterated Hold ratings with identical $2.00 price targets on PGY. They are the only analyst firms I can find that cover this stock despite a sizable market capitalization. Most likely, this has to do with the fact that Pagaya is headquartered outside of the United States.

Balance sheet and risk management

November Company Presentation

November Company Presentation
Approximately one percent of the outstanding float is currently held short. The balance sheet as of the end of the third quarter is highlighted above.

Raised ~$2.1B in capital in 3Q across multiple products

November Company Presentation

November Company Presentation
The two analyst firms that follow the company have it losing between 38 cents to 43 cents a share in FY2022 on roughly $720 million in revenue. As a recent article on Seeking Alpha noted, the stock has faced headwinds since insider lockups starting to expire this September. Share-based compensation totaled $60.3 million in the third quarter.
Management has a long term goal of getting $25 billion in annual loan volume on its platform. Rising interest rates obviously makes the cost of funding more dear. The demand for auto and other loans could also dissipate thanks to higher financing costs. In addition, the economy looks headed into a recession at some point in 2023, and the consumer has lost approximately six percent of their buying power since the beginning of 2021 thanks to the ravages of inflation. Neither trend should be good for delinquency rates.

Stock Event

Seeking Alpha

Seeking Alpha
The company also has little analyst coverage, and that which it has is currently negative. Add in that Pagaya is based in Israel, a place I have not done well investing in small caps historically. RedHill Biopharma (RDHL) being one painful example of. Finally, SPAC-birthed firms have largely done little but destroy shareholder value over the past 12-18 months. Therefore, I am passing on any investment recommendation on PGY despite impressive revenue growth and a relatively attractive price to sales ratio.

Driving strong network volume and revenue growth to date

November Company Presentation

November Company Presentation
A writer who is afraid to overreach himself is as useless as a general who is afraid to be wrong.”― Raymond Chandler
This article was written by
The Busted IPO Forum founded by Bret Jensen, is a hypothetical $200K portfolio built of stocks that have been public for 18 months to five years that are significantly under their offering price. Many times after the initial analyst hyperbole has died and lockups have expired, these same companies can be had for .30 to .50 cents on the dollar from when the shares went public. As lucrative as this niche has been for my portfolio over the years, a service or newsletter has not existed that covered this segment of the market — until now! The goal in creating the Busted IPO Forum is to build a portfolio of 15-20 small cap and mid cap busted IPOs which consistently outperform the Russell 2000 over time. As of 07/02/2021 our model portfolio has generated an overall return of 73.84% substantially above the 52.37% gain from the Russell 2000 over the same time frame.

• • •
Specializing in profiling high beta sectors, Bret Jensen founded and also manages The Biotech Forum, The Insiders Forum, and the Busted IPO Forum model portfolios. Finding “gems” in the biotech and small-cap stock sectors, these highly volatile spaces proven hugely successful have empowered Bret Jensen’s own investing portfolio.

• • •
Learn more about Bret Jensen’s Marketplace offerings:
The Insiders Forum | The Biotech Forum | Busted IPO Forum

Disclosure: I/we have a beneficial long position in the shares of RDHL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

source

Related Articles